Anti-PHD3 antibody
4
(3 Reviews)
|
(20 Publications)
Rabbit Polyclonal PHD3 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 20 publications.
View Alternative Names
Prolyl hydroxylase EGLN3, Egl nine homolog 3, HPH-1, Hypoxia-inducible factor prolyl hydroxylase 3, Prolyl hydroxylase domain-containing protein 3, HIF-PH3, HIF-prolyl hydroxylase 3, HPH-3, PHD3, EGLN3
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PHD3 antibody (AB30782)
ICC/IF image of ab30782 stained HepG2 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab30782 at 5μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- rabbit (ab96899) IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
- WB
Ap16142****
Western blot - Anti-PHD3 antibody (AB30782)
This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 5% Bovine Serum Albumin before being incubated with ab30782 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution.
All lanes:
Western blot - Anti-PHD3 antibody (ab30782) at 1 µg/mL
Lane 1:
Western blot - HeLa-Vehicle treated (Negative Control) Whole Cell Lysate (<a href='/en-us/products/cell-lysates/hela-vehicle-treated-negative-control-whole-cell-lysate-ab116321'>ab116321</a>) at 20 µg
Lane 2:
Hela-DFO treated (0.5mM, 24h) Whole Cell Lysate (<a href='/en-us/products/unavailable/hela-dfo-treated-05mm-24h-whole-cell-lysate-ab116322'>ab116322</a>) at 20 µg
Lane 3:
Human HeLa Nuclear DFO treated at 20 µg
Lane 4:
Human HeLa Cytoplasmic DFO treated at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution
Predicted band size: 27 kDa
Observed band size: 18 kDa,27 kDa
true
Exposure time: 20min
- WB
AbReview36191****
Western blot - Anti-PHD3 antibody (AB30782)
All lanes:
Western blot - Anti-PHD3 antibody (ab30782) at 1/1000 dilution
Lane 1:
Mouse embroyonic fibroblast cell lysate. Treated 21% O2 for 24 hours at 5 µg
Lane 2:
Mouse embroyonic fibroblast cell lysate. Treated 1% O2 for 24 hours at 5 µg
Secondary
All lanes:
Goat polyclonal anti-rabbit HRP-conjugate at 1/10000 dilution
Predicted band size: 27 kDa
true
Exposure time: 30s
This image is courtesy of an anonymous Abreview
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The PHD3 protein plays an essential role in regulating the degradation of HIFs preventing their accumulation under normoxic conditions. It is part of a larger complex which includes oxygen iron and 2-oxoglutarate facilitating its hydroxylase activity. Hydroxylation of HIFs by PHD3 marks them for degradation via the ubiquitin-proteasome pathway preventing HIFs from activating genes related to erythropoiesis angiogenesis and cellular metabolism adaptation to hypoxia. Through these actions PHD3 helps maintain cellular oxygen homeostasis and metabolic balance.
Pathways
PHD3 is integral to the HIF signaling pathway and the cellular response to hypoxia. Its interaction with HIF-1α and HIF-2α is important in this context dictating the stability and activity of these transcription factors under varying oxygen levels. PHD3 also associates with other prolyl hydroxylases such as PHD1 and PHD2 coordinating the regulation of HIFs collectively across different cell types and conditions. These interactions contribute to the modulation of gene expression in response to hypoxic stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (20)
Recent publications for all applications. Explore the full list and refine your search
PeerJ 11:e16242 PubMed37842058
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 19:177 PubMed35810304
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 16:2274-2294 PubMed35298869
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 18:1849-1861 PubMed34339019
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 28:2708-2727 PubMed33875796
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:1341 PubMed33637716
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 12:13513-13525 PubMed33408523
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32708433
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 20: PubMed30832444
2019
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 11:8507-8515 PubMed30555241
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com